You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Bortezomib and thalidomide for the first‑line treatment of multiple myeloma

  • Technology appraisal guidance
  • Reference number: TA228
  • Published:  27 July 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Information for the public

  • Bortezomib and thalidomide as first treatments for multiple myeloma (PDF 61 KB)

    Published:
    27 July 2011
  • Gwybodaeth i'r cyhoedd (Word 329 KB)

    Published:
    31 May 2012
Back to top